Hansen, J. K., Israelsen, M., Nishijima, S., Stinson, S. E., Andersen, P., Johansen, S., Hansen, C. D., Brol, M. J., Klein, S., Schierwagen, R., Uschner, F. E., Sulek, K., Villesen, I. F., Lindvig, K. P., Thorhauge, K. H., Torp, N., Jensen, J. M., Keller, M. I., Jensen, G. H., Detlefsen, S., Leeming, D. J., Stankevic, E., Suvitaival, T., Zawadzki, A., Kuhn, M., Jensen, L. J., Karsdal, M., Trebicka, J., Israelsen, H., Legido-Quigley, C., Bork, P., Arumugam, M., Hansen, T., Thiele, M., Krag, A. (2025). The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial. Nature Communications. https://doi.org/10.1038/s41467-025-60755-9